Norfloxacin 200mg Tablet Franchise in Ahmedabad

UTI & Antibacterial Therapy Supplier in Mumbai

Norflick 200 Tablet Distributor in Delhi

Bacterial Infection Tablet Franchise Opportunity in Bangalore

Fluoroquinolone Antibiotic Tablet Stockist in Hyderabad
Norfloxacin 200mg Export & Manufacturing in Chandigarh

Home/Products /norfloxacin-200mg-tablet

Norflick 200 Tablet

Composition : Norfloxacin (200mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Norflick 200 Tablet contains Norfloxacin 200mg, a fluoroquinolone antibacterial indicated for the treatment of urinary tract infections, prostatitis, and other bacterial infections. It helps in relieving symptoms such as dysuria, urinary urgency, and abdominal discomfort caused by bacterial pathogens.

Norfloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, blocking bacterial replication and ensuring effective eradication of infection. Its higher dosage strength provides enhanced efficacy for moderate to severe infections.

For distributors and healthcare suppliers, Norflick 200 Tablet is a high-demand antibacterial therapy product, widely used in hospitals, clinics, and outpatient care. The ongoing prevalence of UTIs and bacterial infections ensures consistent and stable market demand.

Adding Norflick 200 Tablet to your antibacterial and UTI therapy segment creates strong opportunities in pharmacies, hospitals, urology and general clinics, export markets, and third-party manufacturing. Its proven antibacterial activity, broad clinical application, and prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

Norflick 200 Tablet contains Norfloxacin 200mg, a fluoroquinolone antibacterial indicated for the treatment of urinary tract infections, prostatitis, and other bacterial infections. It helps in relieving symptoms such as dysuria, urinary urgency, and abdominal discomfort caused by bacterial pathogens.

Norfloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, blocking bacterial replication and ensuring effective eradication of infection. Its higher dosage strength provides enhanced efficacy for moderate to severe infections.

For distributors and healthcare suppliers, Norflick 200 Tablet is a high-demand antibacterial therapy product, widely used in hospitals, clinics, and outpatient care. The ongoing prevalence of UTIs and bacterial infections ensures consistent and stable market demand.

Adding Norflick 200 Tablet to your antibacterial and UTI therapy segment creates strong opportunities in pharmacies, hospitals, urology and general clinics, export markets, and third-party manufacturing. Its proven antibacterial activity, broad clinical application, and prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include nausea, vomiting, diarrhea, abdominal discomfort, or dizziness. Rare but serious side effects may include tendonitis, tendon rupture, peripheral neuropathy, CNS effects, or hypersensitivity reactions. Patients should consult their doctor if severe or persistent symptoms occur.

Norflick 200 Tablet is indicated for the treatment of urinary tract infections, prostatitis, and other infections caused by susceptible gram-negative and certain gram-positive bacteria, as prescribed by a healthcare professional.

Norflick 200 Tablet should be taken exactly as prescribed, preferably on an empty stomach or as advised by a healthcare professional. Patients with kidney disease, a history of tendon disorders, or hypersensitivity to fluoroquinolones should inform their doctor before use. Adequate hydration is recommended, and exposure to sunlight or UV light should be limited due to photosensitivity risk.

Store Norflick 200 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use the tablet beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation